Method of preparing poly(ADP-ribose) polymerases inhibitors

Details for Australian Patent Application No. 2005286187 (hide)

Owner Pfizer Inc. Cancer Research Technology Ltd.

Inventors Ma, Chunrong; Stankovic, Nebojsa Slobodan; Nayyar, Naresh

Agent Spruson & Ferguson

Pub. Number AU-B-2005286187

PCT Pub. Number WO2006/033003

Priority 60/612,457 22.09.04 US

Filing date 12 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 18 June 2009

International Classifications

C07D 487/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 223/00 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/033003 Priority application(s): WO2006/033003

11 June 2009 Alteration of Name

  The name of the applicant has been altered to Pfizer Inc.; Cancer Research Technology Ltd.

18 June 2009 Application Accepted

  Published as AU-B-2005286187

15 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286190-Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor

2005286186-4-amino substituted2-substituted-1,2,3,4-tetrahydroquinolin e compounds